Clinical and Radiographic Outcomes of Pulpotomy Versus Pulpectomy in Primary Molars With Symptomatic Irreversible Pulpitis
Condition(s) studied
Investigational drug(s) / intervention(s)
MTA pulp dressing material: The patients with symptomatic irreversible pulpitis in their primary molars was treated by MTA pulpotomy
Metapex: The patients with symptomatic irreversible pulpitis in their primary molars was treated by Metapex pulpectomy
Study summary
The goal of this clinical trial is to learn if MTA pulpotomy compared to pulpectomy have the same clinical and radiographic success in treatment of primary molars diagnosed with symptomatic irreversible pulpitis.
The main questions it aims to answer are:
Does MTA pulpotomy compared to pulpectomy have the same clinical and radiographic success in treatment of primary molars diagnosed with symptomatic irreversible pulpitis?
Eligibility
Primary outcome measure(s)
- proportion of treated teeth demonstrating clinical and functional success during follow up intervals — at 3-month postoperatively, at 6-month postoperatively, at 12-month postoperatively, at 18-month postoperatively
score 0 was applied for non functional teeth and score 1 was applied for functional teeth
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Minia University Dental Hospita | Minya | Egypt |
More Minia University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07783217 on ClinicalTrials.gov ↗ ← All trials in Egypt